“Real-world Effectiveness of Tralokinumab in Adults with Atopic Dermatitis: Interim Data on Improvements in Patients with Head and Neck Atopic Dermatitis after up to 9 Months of Treatment in the TRACE Study” (2025) SKIN The Journal of Cutaneous Medicine, 9(2), p. s574. doi:10.25251/skin.10.supp.574.